Advisory Board member and columnist David Schmiege interviews Stuart A. Harlin, MD, for this issue. Dr. Harlin is an associate professor and the director of outpatient vascular operations within the Department of Cardiothoracic and Vascular Surgery at McGovern Medical School at The University of Texas Health Science Center at Houston.

  Penumbra Inc. has announced its next phase for vascular franchise growth with U.S. commercial availability of the Indigo System Lightning 12 and the appointments of Corey L. Teigen, MD, to chief scientific officer; and James F. Benenati, MD, FSIR, to chief medical officer – two newly created positions. Innovating the

Boston Scientific has been granted a new technology add-on payment (NTPA) for its Eluvia drug-eluting vascular stent system from the Centers for Medicare & Medicaid Services. Under the Inpatient Prospective Payment System (IPPS), CMS pays for a patient’s inpatient hospital stay under one bundled payment, which covers all costs for

PHILIPS TO ACQUIRE INTACT VASCULAR   Royal Philips has signed an agreement to acquire Intact Vascular Inc., a U.S.-based developer of medical devices for minimally invasive peripheral vascular procedures for $275 million upfront deferred payments when the transaction is completed. Intact Vascular will enhance Philips’ image-guided therapy portfolio, combining Philips’

By Larry Storer I generally do not write editor columns, but the staff decided I really needed to write this one because of my perspective as a patient during the COVID-19 pandemic. My medical journey has lasted just longer than 3 months to date – 21/2 months in the hospital